Champions Oncology, Inc. (CSBR) vs Outset Medical, Inc. (OM)

A side-by-side comparison of Champions Oncology, Inc. and Outset Medical, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — CSBR vs OM

growth of $100 · dividends reinvested · last 6y
CSBR -29.5% (-5.7%/yr)OM -99.5% (-59.4%/yr)CSBR compounded faster over this window
Log scale — wide-divergence pair
01101001kStart $100202120222023202420252026$70$0
CSBR OM

CSBR vs OM: by the numbers

  • •OM is the larger company ($76M vs $70M market cap).
  • •Both run net losses; CSBR's is the smaller (-1.87% vs -63.06% net margin).
  • •OM grew revenue faster over the past five years (8.28% vs 7.25% CAGR).

Metrics side by side

Valuation

MetricCSBROM
Forward P/E50.20N/A
P/S ratio1.150.65
P/B ratio17.920.79
EV / EBITDA262.40N/A

Profitability

MetricCSBROM
Gross margin49.30%41.76%
Operating margin-1.72%-56.06%
Net margin-1.87%-63.06%
ROE-29.15%-77.12%
ROIC-6.75%-33.27%

Growth (annualized)

MetricCSBROM
Revenue CAGR (5Y)7.25%8.28%
Total return CAGR (5Y)-13.07%-64.47%

Frequently asked

Which has grown faster, CSBR or OM?
Over the past five years, OM grew revenue faster — CSBR at a 7.25% CAGR versus OM at 8.28%.
How have CSBR and OM total returns compared?
Over the past 5 years, CSBR delivered -13.07% and OM delivered -64.47% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.